about
Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesisNonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells.Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis.The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.The EBV-Encoded Oncoprotein, LMP1, Induces an Epithelial-to-Mesenchymal Transition (EMT) via Its CTAR1 Domain through Integrin-Mediated ERK-MAPK Signalling.
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Epstein-Barr virus at 50-future perspectives.
@en
Epstein-Barr virus at 50-future perspectives.
@nl
type
label
Epstein-Barr virus at 50-future perspectives.
@en
Epstein-Barr virus at 50-future perspectives.
@nl
prefLabel
Epstein-Barr virus at 50-future perspectives.
@en
Epstein-Barr virus at 50-future perspectives.
@nl
P2860
P356
P1476
Epstein-Barr virus at 50-future perspectives.
@en
P2093
Lawrence S Young
P2860
P304
P356
10.5732/CJC.014.10208
P577
2014-11-01T00:00:00Z